Quinaldic acid inhibits proliferation of colon cancer HT-29 cells in vitro: Effects on signaling pathways

European Journal of Pharmacology

Volumn 757, Issue , 2015, Pages 21-27

  Langner, Ewa ^a,b   Walczak, Katarzyna ^a   Jeleniewicz, Witold ^a   Turski, Waldemar A ^a   Rajtar, Grazyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Chemical compounds studied in this article; Quinaldic acid (PubChem CID: 7124)

Indexed keywords

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; QUINALDIC ACID; TRANSCRIPTION FACTOR; ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; QUINOLINE DERIVATIVE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS INHIBITION; ENZYME RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; METABOLIC INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; COLON TUMOR; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HT 29 CELL LINE; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; QUINOLINES; SIGNAL TRANSDUCTION;

EID: 84926391847     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.02.053     Document Type: Article

References (41)

1. A.A. Adjei, and M. Hidalgo Intracellular signal transduction pathway proteins as targets for cancer therapy J. Clin. Oncol. 23 2005 5386 5403
2. F.H. Allen The Cambridge structural database: a quarter of a million crystal structures and rising Acta Crystallogr. B 58 2002 380 388
3. E.C. Anderson, and M.H. Wong Caught in the Akt: regulation of Wnt signaling in the intestine Gastroenterology 139 2010 718 722
4. J.H. Bartram, and P.J. Kent Estimation of zinc in aluminum alloys by means of quinaldinic acid Metallurgia 33 1946 179 181
5. A. Bellacosa, C.C. Kumar, A. Di Cristofano, and J.R. Testa Activation of AKT kinases in cancer: implications for therapeutic targeting Adv. Cancer Res. 94 2005 29 86
6. J.P. Bowden, K.T. Chung, and A. Andrews Mutagenic activity of Trp metabolites produced by rat intestinal microflora J. Natl. Cancer Inst. 57 1976 921 924
7. R.R. Brown, and J.M. Price Quantitative studies on metabolites of tryptophan in the urine of the dog, cat, rat, and man J. Biol. Chem. 219 1956 985 997
8. G.T. Bryan The role of urinary tryptophan metabolites in the etiology of bladder cancer Am. J. Clin. Nutr. 24 1971 841 847
9. T. Colakoglu, S. Yildirim, F. Kayaselcuk, T.Z. Nursal, A. Ezer, T. Noyan, H. Karakayali, and M. Haberal Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence? Am. J. Surg. 195 2008 719 725
10. A.C. Dankers, H.A. Mutsaers, H.B. Dijkman, L.P. van den Heuvel, J.G. Hoenderop, F.C. Sweep, F.G. Russel, and R. Masereeuw Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP) Biochim. Biophys. Acta 1832 2013 1715 1722
11. E.M. Gal, and A.D. Sherman Synthesis and metabolism of l-kynurenine in rat brain J. Neurochem. 30 1978 607 613
12. E. Halilovic, and D.B. Solit Therapeutic strategies for inhibiting oncogenic BRAF signaling Curr. Opin. Pharmacol. 8 2008 419 426
13. R.L. Hanson, P.D. Ray, P. Walter, and H.A. Lardy Mode of action of hypoglycemic agents. I. Inhibition of gluconeogenesis by quinaldic acid and 5-methoxyindole-2-carboxylic acid J. Biol. Chem. 244 1969 4351 4359
14. N. Itoh, S. Semba, M. Ito, H. Takeda, S. Kawata, and M. Yamakawa Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma Cancer 94 2002 127 134
15. M. Kaihara, and J.M. Price The metabolism of quinaldic acid J. Biol. Chem. 237 1962 1727 1729
16. T. König, B. Kocsis, and E. Pocskay Inhibition by quinaldate of dehydrogenases Acta Biochim. Biophys. Acad. Sci. Hung. 10 1975 171 176
17. D. Kuc, M. Rahnama, T. Tomaszewski, W. Rzeski, K. Wejksza, T. Urbanik-Sypniewska, J. Parada-Turska, M. Wielosz, and W.A. Turski Kynurenic acid in human saliva - Does it influence oral microflora? Pharmacol. Rep. 58 2006 393 398
18. D. Kuc, W. Zgrajka, J. Parada-Turska, T. Urbanik-Sypniewska, and W.A. Turski Micromolar concentration of kynurenic acid in rat small intestine Amino Acids 35 2008 503 505
19. C.H. Lee, and H.S. Lee Growth inhibiting activity of quinaldic acid isolated from Ephedra pachyclada against intestinal bacteria J. Korean Soc. Appl. Biol. Chem. 52 2009 331 335
20. J.T. Litchfield, and F.A. Wilcoxon A simplified method of evaluating dose-effect experiments J. Pharmacol. Exp. Ther. 96 1949 99 113
21. S. Maddika, G.H. Bay, T.J. Kroczak, S.R. Ande, S. Maddika, E. Wiechec, S.B. Gibson, and M. Los Akt is transferred to the nucleus of cells treated with apoptin, and it participates in apoptin-induced cell death Cell Prolif. 40 2007 835 848
22. S. Maddika, S. Panigrahi, E. Wiechec, S. Wesselborg, U. Fischer, K. Schulze-Osthoff, and M. Los Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity Mol. Cell Biol. 29 2009 1235 1248
23. Y. Mebratu, and Y. Tesfaigzi How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle 8 2009 1168 1175
24. H.A. Mutsaers, L.P. van den Heuvel, L.H. Ringens, A.C. Dankers, F.G. Russel, J.F. Wetzels, J.G. Hoenderop, and R. Masereeuw Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations PLoS One 6 4 2011 e18438
25. Y. Noto, and H. Okamoto Inhibition by kynurenine metabolites of proinsulin synthesis in isolated pancreatic islets Acta Diabetol. Lat. 15 1978 273 282
26. H. Okamoto, S. Miyamoto, H. Mabuchi, and R. Takeda Inhibitory effect of quinaldic acid on glucose-induced insulin release from isolated Langerhans islets of the rat Biochem. Biophys. Res. Commun. 59 1974 623 629
27. H. Okamoto, S. Miyamoto, H. Mabuchi, Y. Yoneyama, and R. Takeda Insulin-releasing effect of quinaldic acid and its relatives on isolated Langerhans islets Biochem. Biophys. Res. Commun. 53 1973 1297 1303
28. P. Paluszkiewicz, W. Zgrajka, T. Saran, J. Schabowski, J.L. Piedra, O. Fedkiv, S. Rengman, S.G. Pierzynowski, and W.A. Turski High concentration of kynurenic acid in bile and pancreatic juice Amino Acids 37 2009 637 641
29. O.M. Rollano Peñaloza, M. Lewandowska, J. Stetefeld, K. Ossysek, M. Madej, J. Bereta, M. Sobczak, S. Shojaei, S. Ghavami, and M.J. Los Apoptins: selective anticancer agents Trends Mol. Med. 20 2014 519 528
30. S. Sampurno, A. Bijenhof, D. Cheasley, H. Xu, S. Robine, D. Hilton, W.S. Alexander, L. Pereira, T. Mantamadiotis, J. Malaterre, and R.G. Ramsay The Myb-p300-CREB axis modulates intestine homeostasis, radiosensitivity and tumorigenesis Cell Death Dis. 4 2013 e605
31. M.P. Turski, P. Kamiński, W. Zgrajka, M. Turska, and W.A. Turski Potato - an important source of nutritional kynurenic acid Plant Foods Hum. Nutr. 67 2012 17 23
32. M.P. Turski, M. Turska, W. Zgrajka, M. Bartnik, T. Kocki, and W.A. Turski Distribution, synthesis, and absorption of kynurenic acid in plants Planta Med. 77 2011 858 864
33. M.P. Turski, M. Turska, W. Zgrajka, D. Kuc, and W.A. Turski Presence of kynurenic acid in food and honeybee products Amino Acids 36 2009 75 80
34. C.M. Veneziale, P. Walter, N. Kneer, and H.A. Lardy Influence of l-tryptophan and its metabolites on gluconeogenesis in the isolated, perfused liver Biochemistry 6 1967 2129 2138
35. K. Walczak, W. Dąbrowski, E. Langner, W. Zgrajka, J. Piłat, T. Kocki, W. Rzeski, and W.A. Turski Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells Scand. J. Gastroenterol. 46 2011 903 912
36. K. Walczak, S. Deneka-Hannemann, B. Jarosz, W. Zgrajka, F. Stoma, T. Trojanowski, W.A. Turski, and W. Rzeski Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells Pharmacol. Rep. 66 2014 130 136
37. K. Walczak, W.A. Turski, and G. Rajtar Kynurenic acid inhibits colon cancer proliferation in vitro: effects on signaling pathways Amino Acids 46 2014 2393 2401
38. K. Walczak, W.A. Turski, and W. Rzeski Kynurenic acid enhances expression of p21 Waf1/Cip1 in colon cancer HT-29 cells Pharmacol. Rep. 64 2012 745 750
39. K. Walczak, M. Zurawska, J. Kis, R. Starownik, W. Zgrajka, K. Bar, W.A. Turski, and W. Rzeski Kynurenic acid in human renal cell carcinoma: its antiproliferative and antimigrative action on Caki-2 cells Amino Acids 43 2012 1663 1670
40. I. Yokoi, Y. Nishijima, A. Uchida, H. Kabuto, N. Yamamoto, and N. Ogawa Effects of kynurenine metabolites on the electrocorticographic activity in the rat J. Neural. Transm. 105 1998 147 160
41. W. Zgrajka, M. Turska, G. Rajtar, M. Majdan, and J. Parada-Turska Kynurenic acid content in anti-rheumatic herbs Ann. Agric. Environ. Med. 20 2013 800 802